These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27272796)

  • 21. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
    Seiwert TY; Burtness B; Mehra R; Weiss J; Berger R; Eder JP; Heath K; McClanahan T; Lunceford J; Gause C; Cheng JD; Chow LQ
    Lancet Oncol; 2016 Jul; 17(7):956-965. PubMed ID: 27247226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible?
    Gleich LL; Ryzenman J; Gluckman JL; Wilson KM; Barrett WL; Redmond KP
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):35-8. PubMed ID: 14732765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head and neck in situ carcinoma: survival analysis of the Thuringian cancer registration database.
    Guntinas-Lichius O; Wendt T; Buentzel J; Esser D; Lochner P; Mueller A; Schultze-Mosgau S; Altendorf-Hofmann A;
    Oral Oncol; 2010 Apr; 46(4):e5-9. PubMed ID: 20227329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of extracapsular spread in isolated neck recurrences in head and neck squamous cell carcinoma patients.
    León X; Rigó A; Farré N; López M; García J; de Juan J; Quer M
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):527-533. PubMed ID: 27509897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer.
    Teckie S; Scala LM; Ho F; Wolden S; Chiu J; Cohen GN; Wong R; Ganly I; Zelefsky MJ; Lee NY
    Brachytherapy; 2013; 12(3):228-34. PubMed ID: 23466361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
    Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL
    Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic factors affecting results of comprehensive treatment of hypopharyngeal carcinoma].
    Xu W; Lyu Z; Yang Z; Zou J; Cao H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):533-8. PubMed ID: 25257265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA.
    Pagh A; Vedtofte T; Lynggaard CD; Rubek N; Lonka M; Johansen J; Andersen E; Kristensen CA; von Buchwald C; Andersen M; Godballe C; Overgaard J; Grau C
    Acta Oncol; 2013 Feb; 52(2):277-84. PubMed ID: 23320772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck.
    Boysen M; Lövdal O; Tausjö J; Winther F
    Eur J Cancer; 1992; 28(2-3):426-30. PubMed ID: 1591057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
    Machiels JP; Haddad RI; Fayette J; Licitra LF; Tahara M; Vermorken JB; Clement PM; Gauler T; Cupissol D; Grau JJ; Guigay J; Caponigro F; de Castro G; de Souza Viana L; Keilholz U; Del Campo JM; Cong XJ; Ehrnrooth E; Cohen EE;
    Lancet Oncol; 2015 May; 16(5):583-94. PubMed ID: 25892145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Type 2 Diabetes Mellitus on Survival in Head and Neck Squamous Cell Carcinoma.
    Foreman A; Lee DJ; McMullen C; de Almeida J; Muhanna N; Gama RR; Giuliani M; Liu G; Bratman SV; Huang SH; O'Sullivan B; Song Y; Xu W; Goldstein DP
    Otolaryngol Head Neck Surg; 2017 Oct; 157(4):657-663. PubMed ID: 28849730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma.
    Kim DH; Gong EJ; Jung HY; Lim H; Ahn JY; Choi KS; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY; Baek S
    Scand J Gastroenterol; 2014 Dec; 49(12):1486-92. PubMed ID: 25372595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elective lymphadenectomy during salvage for locally recurrent head and neck squamous cell carcinoma after radiation.
    Prendes BL; Aubin-Pouliot A; Egbert N; Ryan WR
    Otolaryngol Head Neck Surg; 2014 Sep; 151(3):462-7. PubMed ID: 24894423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
    Soulières D; Faivre S; Mesía R; Remenár É; Li SH; Karpenko A; Dechaphunkul A; Ochsenreither S; Kiss LA; Lin JC; Nagarkar R; Tamás L; Kim SB; Erfán J; Alyasova A; Kasper S; Barone C; Turri S; Chakravartty A; Chol M; Aimone P; Hirawat S; Licitra L
    Lancet Oncol; 2017 Mar; 18(3):323-335. PubMed ID: 28131786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center.
    Schmidt C; Martin JM; Khoo E; Plank A; Grigg R
    Head Neck; 2015 Dec; 37(12):1808-15. PubMed ID: 24995842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tumour recurrence in squamous head and neck cancer].
    Alvarez Marcos CA; Llorente Pendás JL; Franco Gutiérrez V; Fernández Espina H; Alonso Guervós M; Suárez Nieto C; Hermsen M
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):156-63. PubMed ID: 17428412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High b-Value Diffusion MRI to Differentiate Recurrent Tumors from Posttreatment Changes in Head and Neck Squamous Cell Carcinoma: A Single Center Prospective Study.
    Acampora A; Manzo G; Fenza G; Busto G; Serino A; Manto A
    Biomed Res Int; 2016; 2016():2865169. PubMed ID: 27376081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.
    Strnad V; Lotter M; Kreppner S; Fietkau R
    Brachytherapy; 2014; 13(2):187-95. PubMed ID: 24211123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.